Innovative Pharma Pricing & Market Access Strategies Summit
27-28

March 2017

Spain

Barcelona

Silken Gran Hotel Havana

Gran Via de les Corts Catalanes 647, 08010

About

This premier B2B event will enable the participants to learn about the latest developments and provide the appropriate platform for dialogue and networking with peers involved in Pharma Pricing & Market Access. The Summit will shed light on current Pharma Pricing & Market Access challenges, best practice, new solutions, and trends of today and those we anticipate in the future in Pharma Pricing & Market Access. At this Summit you will have an unprecedented opportunity to learn from some of the most renowned experts in the field that will enab...

This premier B2B event will enable the participants to learn about the latest developments and provide the appropriate platform for dialogue and networking with peers involved in Pharma Pricing & Market Access. The Summit will shed light on current Pharma Pricing & Market Access challenges, best practice, new solutions, and trends of today and those we anticipate in the future in Pharma Pricing & Market Access. At this Summit you will have an unprecedented opportunity to learn from some of the most renowned experts in the field that will enable you to put into practice whta you learnt in the future, resulting in significant advantages that will enable you to overtake your competitors in the market.

more info
Who Should Attend

CEOs / Presidents / MDs, CCOs/CMOs/CDOs, Chief Executives, Directors, Vice Presidents, Department Heads, Leaders and Managers specialising in:

  • Business Development
  • Sales
  • Market Access
  • Marketing Intelligence
  • Product Launch
  • Pricing Policy
  • Health Technology Assessment
  • Health Informatics
  • Value Strategy
  • Tendering
  • Marketing
  • Pricing
  • Medical Director
  • Drug Pricing
  • Health Economics
  • Product Reimbursement
  • Real World Evidence
  • Data Sciences
  • P&MA

From Industries Including:

  • Biotechnology
  • Pharmaceuticals
Key Practical Learning Points of the Summit

  • The impact of pricing policies on Pharmaceutical Innovation
  • Biosimilars and their influence on pricing and reimbursement
  • Pricing strategy: Price premiums vs discounts: What’s best?
  • Balancing value & affordability for a new orphan product
  • Improving value proposition with HTA
  • Development of alternative payment models
  • Persuading payers for expensive new treatments with RWE
  • Fostering a successful tendering management strategy
  • Ensuring market access success
  • Maximizing your market access strategies by knowing regulatory trends
  • Patient-centered approaches that help advance market access goals
  • The contribution of marketing intelligence to pharmaceutical market access
Speakers
John Alter

VP Global Health & Value Global Established Pharma Business Unit

Pfizer

Adam Levysohn

Senior Director, Global Market Access Lead – Biosimilars

Biogen

Dr. Anne Marciniak

Senior Director European HEOR

Allergan

Anne-Toni Rodgers

Head Global Payer Evidence & Pricing

Astrazeneca

Mona Khalid

Senior Director Head Evidence & Value Generation

Takeda

Klaas Postema

Senior Director Market Access & Pricing

Generics Europe Actavis

Prof Peter Rutherford MD PhD

Vice President Integrated Market Access

QuintilesIMS

Bertrand Tardivel

Head of Global Pricing

Takeda

Oliver Leatham

Vice President / Global Head of Pricing & Market Access

Parexel

Dražen Jeleč, MD, MBA

Market Access Director

Market Access Director

Annual

Events

Sponsors and Partners

Media partner

Media partner

Media partner